Republic of Korea vs Lithuania: Previously treated cases tested for RR-/MDR-TB
Republic of Korea
100.0%
in 2024
Lithuania
100.0%
in 2024
Republic of Korea rank
1st
Lithuania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Republic of Korea
- Lithuania
How they compare
Republic of Korea currently reports 100.0% against 100.0% in Lithuania, a difference of 0.0%.
Across all 13 years both countries report, Lithuania has been ahead every year.
Republic of Korea ranks 1st and Lithuania ranks 1st of 180 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Korea | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 100.0% | 44.5% | Lithuania |
| 2020s | 92.0% | 100.0% | 8.0% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Republic of Korea or Lithuania?
- Republic of Korea, at 100.0% against 100.0% in Lithuania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Republic of Korea and Lithuania?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Lithuania?
- 13 years are reported by both, from 2011 to 2024.
- How do Republic of Korea and Lithuania rank globally for previously treated cases tested for rr-/mdr-tb?
- Republic of Korea ranks 1st and Lithuania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.